Wells Fargo & Company Bio Affinity Technologies, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.42 - $3.0 $5 - $12	4 Added 9.76%	45 $0
Q4 2023 Feb 09, 2024	BUY	$1.18 - $1.69 $3 - $5	3 Added 7.89%	41 $0
Q3 2023 Nov 13, 2023	BUY	$0.99 - $1.9 $1 - $3	2 Added 5.56%	38 $0
Q2 2023 Aug 15, 2023	BUY	$1.56 - $2.05 $3 - $4	2 Added 5.88%	36 $0
Q1 2023 May 12, 2023	BUY	$1.52 - $3.06 $10 - $21	7 Added 25.93%	34 $0
Q4 2022 Feb 13, 2023	BUY	$1.6 - $3.14 $43 - $84	27 New	27 $0

468K

Ticker BIAF
Exchange
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 2,727,580
Market Cap $2.43M
Description
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.